Skip to main content

Volume 12 Supplement 1

Selected articles from the International Conference on Intelligent Biology and Medicine (ICIBM) 2018: medical genomics


Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.

Los Angeles, CA, USA10-12 June 2018

Edited by Xiaoming Liu, Lei Xie, Zhijin Wu, Kai Wang, Zhongming Zhao, Jianhua Ruan and Degui Zhi.

Conference website

Related articles have been published as supplements to BMC Bioinformatics (Part 1 and Part 2), BMC Genomics, BMC Medical Informatics and Decision Making and BMC Systems Biology.

  1. During June 10–12, 2018, the International Conference on Intelligent Biology and Medicine (ICIBM 2018) was held in Los Angeles, California, USA. The conference included 11 scientific sessions, four tutorials, ...

    Authors: Degui Zhi, Zhongming Zhao, Fuhai Li, Zhijin Wu, Xiaoming Liu and Kai Wang
    Citation: BMC Medical Genomics 2019 12(Suppl 1):20
  2. Predicting cellular responses to drugs has been a major challenge for personalized drug therapy regimen. Recent pharmacogenomic studies measured the sensitivities of heterogeneous cell lines to numerous drugs,...

    Authors: Xuewei Wang, Zhifu Sun, Michael T. Zimmermann, Andrej Bugrim and Jean-Pierre Kocher
    Citation: BMC Medical Genomics 2019 12(Suppl 1):15
  3. While changes in mRNA expression during tumorigenesis have been used widely as molecular biomarkers for the diagnosis of a number of cancers, the approach has limitations. For example, traditional methods do n...

    Authors: Fan Zhang, Linda Ding, Li Cui, Robert Barber and Bin Deng
    Citation: BMC Medical Genomics 2019 12(Suppl 1):25
  4. Identifying cancer driver genes (CDG) is a crucial step in cancer genomic toward the advancement of precision medicine. However, driver gene discovery is a very challenging task because we are not only dealing...

    Authors: Alice Djotsa Nono, Ken Chen and Xiaoming Liu
    Citation: BMC Medical Genomics 2019 12(Suppl 1):22
  5. At least 90% of human genes are alternatively spliced. Alternative splicing has an important function regulating gene expression and miss-splicing can contribute to risk for human diseases, including Alzheimer...

    Authors: Seonggyun Han, Jason E. Miller, Seyoun Byun, Dokyoon Kim, Shannon L. Risacher, Andrew J. Saykin, Younghee Lee and Kwangsik Nho
    Citation: BMC Medical Genomics 2019 12(Suppl 1):13
  6. Prognostic signatures are vital to precision medicine. However, development of somatic mutation prognostic signatures for cancers remains a challenge. In this study we developed a novel method for discovering ...

    Authors: Mark Menor, Yong Zhu, Yu Wang, Jicai Zhang, Bin Jiang and Youping Deng
    Citation: BMC Medical Genomics 2019 12(Suppl 1):24
  7. Although synonymous single nucleotide variants (sSNVs) do not alter the protein sequences, they have been shown to play an important role in human disease. Distinguishing pathogenic sSNVs from neutral ones is ...

    Authors: Fang Shi, Yao Yao, Yannan Bin, Chun-Hou Zheng and Junfeng Xia
    Citation: BMC Medical Genomics 2019 12(Suppl 1):12
  8. While most pediatric sarcomas respond to front-line therapy, some bone sarcomas do not show radiographic response like soft-tissue sarcomas (rhabdomyosarccomas) but do show 90% necrosis. Though, new therapies ...

    Authors: Lijun Cheng, Pankita H. Pandya, Enze Liu, Pooja Chandra, Limei Wang, Mary E. Murray, Jacquelyn Carter, Michael Ferguson, Mohammad Reza Saadatzadeh, Khadijeh Bijangi-Visheshsaraei, Mark Marshall, Lang Li, Karen E. Pollok and Jamie L. Renbarger
    Citation: BMC Medical Genomics 2019 12(Suppl 1):23
  9. Haplotype phasing is an important step in many bioinformatics workflows. In cancer genomics, it is suggested that reconstructing the clonal haplotypes of a tumor sample could facilitate a comprehensive underst...

    Authors: Yixuan Wang, Xuanping Zhang, Shuai Ding, Yu Geng, Jianye Liu, Zhongmeng Zhao, Rong Zhang, Xiao Xiao and Jiayin Wang
    Citation: BMC Medical Genomics 2019 12(Suppl 1):27
  10. Cleft lip (CL) is one of the most common congenital birth defects with complex etiology. While genome-wide association studies (GWAS) have made significant advances in our understanding of mutations and their ...

    Authors: Aimin Li, Guimin Qin, Akiko Suzuki, Mona Gajera, Junichi Iwata, Peilin Jia and Zhongming Zhao
    Citation: BMC Medical Genomics 2019 12(Suppl 1):16
  11. The study of high-throughput genomic profiles from a pharmacogenomics viewpoint has provided unprecedented insights into the oncogenic features modulating drug response. A recent study screened for the respons...

    Authors: Yu-Chiao Chiu, Hung-I Harry Chen, Tinghe Zhang, Songyao Zhang, Aparna Gorthi, Li-Ju Wang, Yufei Huang and Yidong Chen
    Citation: BMC Medical Genomics 2019 12(Suppl 1):18

    The Correction to this article has been published in BMC Medical Genomics 2019 12:119

  12. Cardiovascular disease, diabetes, and kidney disease are among the leading causes of death and disability worldwide. However, knowledge of genetic determinants of those diseases in African Americans remains li...

    Authors: Xueyan Zhao, Xin Geng, Vinodh Srinivasasainagendra, Ninad Chaudhary, Suzanne Judd, Virginia Wadley, Orlando M. Gutiérrez, Henry Wang, Ethan M. Lange, Leslie A. Lange, Daniel Woo, Frederick W. Unverzagt, Monika Safford, Mary Cushman, Nita Limdi, Rakale Quarells…
    Citation: BMC Medical Genomics 2019 12(Suppl 1):26
  13. Normal tissue samples are often employed as a control for understanding disease mechanisms, however, collecting matched normal tissues from patients is difficult in many instances. In cancer research, for exam...

    Authors: William Z. D. Zeng, Benjamin S. Glicksberg, Yangyan Li and Bin Chen
    Citation: BMC Medical Genomics 2019 12(Suppl 1):21

Annual Journal Metrics

  • 2022 Citation Impact
    2.7 - 2-year Impact Factor
    3.2 - 5-year Impact Factor
    0.730 - SNIP (Source Normalized Impact per Paper)
    0.892 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    164 days submission to accept (Median)

    2023 Usage 
    593 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal